Belén Garijo has been recognized among the most influential CEOs in oncology. She is also listed among the most powerful women in business and one of the women running Europe, indicating her significant influence in the industry and beyond. The recognition of her company, Merck KGaA, is also noted in relation to a new priority voucher.